BridgeBio Pharma, Inc. (BBIO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

SA Transcripts 162.16K Followers Follow BridgeBio Pharma, Inc. ( BBIO ) 12th Annual Cantor Fitzgerald Global Healthcare Conference September 10, 2026 9:10 AM EDT Company Participants Chinmay Shukla - Senior Vice President of Strategic Finance Anna Wade - BD & Operations Julie Everett - Chief Operating Officer of Skeletal Dysplasias Conference Call Participants Joshua Schimmer - Cantor Fitzgerald & Co., Research Division Presentation Joshua Schimmer Cantor Fitzgerald & Co., Research Division Welcome, everyone. I'm Josh Schimmer from the Cantor Biotech Equity Research team. I'm very pleased to introduce from BridgeBio. We have Chinmay Shukla, immediately to my right, SVP of Investor Relations and Strategic Finance. Next to Chinmay, we have Anna Wade, Chief Operating Officer of BridgeBio Neuromuscular. And beside Anna, we have Julie Miller Everett, not Everett Miller, we caught that, Chief Operating Officer of BridgeBio Skeletal Dysplasias. So great to have the team with us. Question-and-Answer Session Joshua Schimmer Cantor Fitzgerald & Co., Research Division Chinmay, maybe you want to kick things off, give us a quick snapshot of where BridgeBio is today and where the company is headed? Chinmay Shukla Senior Vice President of Strategic Finance Yes. Happy to do that. First, Josh, thank you for hosting us, and thank you to all the investors for joining us here and as well as on our one-on-ones. So BridgeBio today is at an inflection point. We have $8 billion in post-Phase III peak year sales assets. The first of that is Attruby, which is launched, which we think is a $4 billion drug. Globally, it was already annualizing to over $1 billion in 2Q. So we're building on our strength there. Right after that, we have 3 launches upcoming very shortly now. I think the first one, limb-girdle, is going to be in November. And then we expect to launch in achondroplasia as well as ADH1 sort of early next year. So that's